Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Esophageal Squamous Cell Carcinoma × tislelizumab × Clear all

Phase

Phase 2 13 Phase 3 3 Phase 1 2 Phase EARLY_PHASE1 1 Phase 4 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 2 Small Cell Lung Carcinoma 1 Recurrence 1 Non-Muscle Invasive Bladder Neoplasms 1 Hodgkin Disease 1 Esophageal Squamous Cell Carcinoma 1 Breast Neoplasms 1

Interventions

Cisplatin 2 tislelizumab 1 Radiotherapy 1 Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05603065 2023-06-29

TINES

First Affiliated Hospital Xi'an Jiaotong University

Phase 4 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡